Renhe Pharmacy Co

Renhe Pharmacy Co AAQS

The The AAQS of Renhe Pharmacy Co (000650.SZ) as of Oct 16, 2026 is 4. In the previous year, The AAQS was 4.00 — a change of 0.00% (lower).

AAQS

4

YoY

0.00%

Last updated:

Renhe Pharmacy Co has a current AAQS of 4.

A high AAQS can be seen as a positive indicator that the company is developing successfully.

Investors can assume that the company is on a good path to generate profits.

On the other hand, it is important to consider the AAQS of the stock Renhe Pharmacy Co in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.

In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.

The Renhe Pharmacy Co AAQS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

AAQS
Date
AAQS
Jan 1, 2018
4.00 CNY
Jan 1, 2019
4.00 CNY
Jan 1, 2020
4.00 CNY
Jan 1, 2021
4.00 CNY
Jan 1, 2022
4.00 CNY
Jan 1, 2023
4.00 CNY
Jan 1, 2024
4.00 CNY
Jan 1, 2025
4.00 CNY
The Renhe Pharmacy Co AAQS history
YEARAAQSYoY
40.00%
40.00%
40.00%
40.00%
40.00%
40.00%
40.00%
40.00%
40.00%
40.00%
40.00%
4—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Renhe Pharmacy Co Stock analysis

What does Renhe Pharmacy Co do? Renhe Pharmacy Co Ltd is a pharmaceutical company based in Nanchang, China, operating within the Health Care sector. The company, listed on the Shenzhen Stock Exchange under ticker 000650.SZ, has been publicly traded since its IPO on December 10, 1996. Renhe Pharmacy employs 6,062 full-time staff and focuses on the manufacturing and distribution of pharmaceutical products. Its product portfolio includes various dosage forms such as capsules, granules, tablets, powders, injections, suppositories, and ointments. The company operates primarily within China, distributing its products domestically. Renhe Pharmacy is engaged in both the industrial manufacturing of pharmaceuticals and the retail and wholesale distribution of health-related products. The firm's headquarters are located in Nanchang, Jiangxi Province, and it maintains a website at https://www.renheyaoye.com/photography, though the content of the site is not detailed here. The company's activities are centered around the production and sale of pharmaceuticals, with no indication of international operations or significant acquisitions beyond the information provided. The business model emphasizes domestic market presence, serving both medical institutions and consumers through its product range. Renhe Pharmacy Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Renhe Pharmacy Co stock

The AAQS of Renhe Pharmacy Co is 4 in 2025.

On Eulerpool you can find the complete historical development of The AAQS Renhe Pharmacy Co since 2006 – with annual values, charts, and detailed analysis.

The AAQS is a key figure developed by AlleAktien.

The AAQS is a key figure developed by AlleAktien.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Renhe Pharmacy Co

All Key Metrics — Renhe Pharmacy Co